All News #Library
Sciences
RedHill Biopharma combines Opaganib and Darolutamide in advanced
03 Jul 2025 //
INDPHARMAPOST
RedHill, Medscape to Launch H. Pylori Program at Congress
05 May 2025 //
PR NEWSWIRE
RedHill and HealthCare Agree to Extinguish All RedHill`s Debt Obligations
06 Feb 2023 //
PR NEWSWIRE
ObvioHealth and RedHill to begin remote Covid-19 therapy trial
03 Mar 2021 //
CLINICALTRIALSARENA
RedHill Biopharma Announces $10 Million Bought Deal Offering
02 Mar 2021 //
PRNEWSWIRE
Der RedHill-Phase-II/III-Kandidat Opaganib reduziert ARDS-bedingte Blutgerinnung
17 Dec 2020 //
PRNEWSWIRE

Market Place
Sourcing Support